🇺🇸 FDA
Pipeline program

LBR-101 High Dose

LBR-101-021

Phase 2 small_molecule completed

Quick answer

LBR-101 High Dose for Chronic Migraine is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Chronic Migraine
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials